Meet the Startups
5/19 USA, 5/20 Japan
AvodahMed is an advanced technology company, employing artificial intelligence, protected by 12 awarded patents. This incredibly special AI sits between the doctor and the patient. This technology using computer visioning allows the doctor to see vital signs, respiration, eye dilation and other longitudinal patient data. This technology also has a translation feature that if the patient is speaking a language other than English (i.e. Malay) it provides real time natural language translation. This live, real time, HIPAA compliant video conferencing is aimed to simulate a face-to-face visit between doctor and patient. Not only are physician practices potential clients but other companies employing telehealth conferencing who only use flat video.
Casana is unlocking a new category in healthcare technologies that enables effortless, integrated and consistent in-home heart health monitoring. Casana’s first product, The Heart Seat™ is an IoT heart health toilet seat that captures clinically relevant measurements, including heart rate, blood pressure, blood oxygenation, and cardiac output. Casana’s mission is to assist medical teams in their care management of patients with chronic conditions beyond the four walls of the hospital, starting with the 6M+ people in the US living with Heart Failure. Casana was founded in 2018 by Dr. Nicholas Conn, whose vision it was to use passive, connected sensors to solve the challenges for managing health at home. He developed The Heart Seat during his PhD work at the Rochester Institute of Technology (RIT).
CereVu has developed a wireless wearable sensor for use in both hospitals and remote settings. The device continuously measures pain, dyspnea, SpO2, heart rate, respiration rate and body temperature in real-time to enable optimal patient care. With support from the National Science Foundation, the company has validated the pain and dyspnea algorithms. CereVu is now in the process of raising capital for final product validation, FDA clearance and pilot commercialization.
Digital Diagnostics Inc. (formerly IDx) is a pioneering AI diagnostics company on a mission to transform the quality, accessibility, equity, and affordability of healthcare. It was founded and is led by Michael Abramoff, MD, PhD, a practicing, fellowship-trained retina specialist ophthalmologist, neuroscientist and computer engineer. Digital Diagnostics’ platform includes two autonomous AI systems, IDx-DR and DermSpot. Digital Diagnostics is paving the way for autonomous AI diagnosis to become a new standard of care, contributing to democratizing healthcare and closing care gaps. The company works closely with patient advocacy groups, federal regulators, and other quality of care and ethics-focused stakeholders to enable adoption of autonomous AI. For more information and the latest news follow: https://dxs.ai
Eko enables clinicians with the ability to provide the best cardiac care possible. We are a committed partner to the providers and scientists on the front lines of care. We create digital health solutions that enable healthcare providers, researchers and entire health systems to change how we care for the heart. Together, we can evolve the science of auscultation and empower the art of caring.
Epicore Biosystems, Inc. develops wearable microfluidic products and analytics solutions that are capable of non-invasively measuring metabolic and digital biomarkers in real-time, across a range of applications including worker safety, sports and fitness, and remote healthcare. Epicore has established partnerships with Fortune 100 companies, the Department of Defense, and leading research hospitals to drive personalized care with its proprietary wearable microfluidic products.
Nozomi is a Japanese medical device startup focused on developing and commercializing Longevity and Aging technologies in Japan and beyond. Formed by medical device veterans Daniel Burnett, Rob Claar, Yuko Terasawa and Shungo Adachi, Nozomi will first be focused on the development and commercialization of a revolutionary home monitoring technology licensed from Respirix, a venture-capital backed startup in San Francisco.
Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostic, and treatment monitoring for diseases with high unmet clinical needs. We apply AI to raw ultrasound images from low-cost hand-held devices. Our initial focus is on liver disease.
TheraB is the creator of SnugLit, the first wearable treatment for infant jaundice. SnugLit is a wearable, portable phototherapy device that provides 360-degree blue light coverage from the inside of a baby swaddle. SnugLit is designed to be worn by the infant, eliminating separation and allowing loved ones to freely hold, interact, bond, and breastfeed with the newborn. With the help of over 300 nurses, physicians, and parents, we’ve developed SnugLit to prioritize both effective treatment and the sacred time between mom and baby during the first week of life. TheraB owns a full utility patent for this device, and it will be paid for by the insurer using pre-existing codes for phototherapy.
Join Our Newsletter
Stay up to date on upcoming Japan Society events and activities.